Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10011718751
Persistent link: https://www.econbiz.de/10014336552
We study international trade in a model where consumers have non-homothetic preferences and where household income restricts the extensive margin of consumption. In equilibrium, monopolistic producers set high (low) prices in rich (poor) countries but a threat of parallel trade restricts the...
Persistent link: https://www.econbiz.de/10010316059
Persistent link: https://www.econbiz.de/10008695835
Persistent link: https://www.econbiz.de/10003383141
Persistent link: https://www.econbiz.de/10003390236
We study international trade in a model where consumers have non-homothetic preferences and where household income restricts the extensive margin of consumption. In equilibrium, monopolistic producers set high (low) prices in rich (poor) countries but a threat of parallel trade restricts the...
Persistent link: https://www.econbiz.de/10013139153
Persistent link: https://www.econbiz.de/10003846213
Providing health insurance involves a trade-off between the benefits from risk spreading and the costs due to moral hazard. Focusing on pharmaceuticals consumption, this paper examines theoretically whether reference pricing, requiring individuals to pay the price difference if, in this case,...
Persistent link: https://www.econbiz.de/10011019119
Should governments allow parallel trade of pharmaceuticals? There is no clear-cut answer to this question, since parallel trade causes some public concerns. One is that prices might not decrease much in the home country because consumers are price insensitive as a result of medical insurance....
Persistent link: https://www.econbiz.de/10005016228